# Gadoxetic Acid–enhanced MRI Radiomics Features of Tumor Margins for Predicting High-Risk Solitary Hepatocellular Carcinoma Aggressiveness and Prognosis

**Authors:** Can Yu, Xinxin Wang, Shuli Tang, Yan Li, Shuai Han, Qiuju Zhang, Jinrong Qu, Haitao Xu, Yang Zhou

PMC · DOI: 10.1148/rycan.250220 · Radiology: Imaging Cancer · 2026-01-23

## TL;DR

This study uses MRI radiomics to predict aggressive features in liver cancer by analyzing tumor margins, improving prognosis and treatment planning.

## Contribution

The novel contribution is a radiomics model using EOB-MRI tumor margin features to predict microvascular invasion and prognosis in high-risk hepatocellular carcinoma.

## Key findings

- The radiomics model achieved AUCs of 0.80 in training and 0.72 in external testing for predicting microvascular invasion.
- High optimal margin region scores correlated with extracellular matrix remodeling and M2 macrophage infiltration.
- The model effectively stratified patients by overall and disease-free survival.

## Abstract

To develop a radiomics model based on hepatobiliary phase gadolinium
ethoxybenzyl-diethylenetriaminepentaacetic acid (EOB)–enhanced
MRI features at the tumor margin to predict microvascular invasion in
high-risk solitary hepatocellular carcinoma (HR-sHCC), determine the
optimal margin region, and explore the underlying biologic
mechanisms.

This retrospective study included patients with HR-sHCC from three
medical centers between April 2015 and December 2022. Radiomics features
were extracted from 121 volumes of interest (VOIs) at the tumor margin
at EOB MRI. Nine combinations of statistical and machine learning
methods were used to construct and validate the optimal margin
region–based radiomics model. Model performance was assessed
using the area under the receiver operating characteristic curve (AUC),
and patient stratification was evaluated with Kaplan–Meier and
log-rank analyses. RNA sequencing data underwent differential expression
analysis with DESeq2, followed by Kyoto Encyclopedia of Genes and
Genomes (ie, KEGG) and Gene Ontology (ie, GO) enrichment, and immune
cell infiltration was assessed using xCell and EPIC.

A total of 436 patients (mean age, 57.7 years ± 8.8 [SD]; 352
male) were included: 254 in the training, 108 in the internal test, and
74 in the external test cohorts. Receiver operating characteristic
analysis showed AUCs of 0.80 (95% CI: 0.74, 0.86), 0.76 (95% CI: 0.66,
0.85), and 0.72 (95% CI: 0.58, 0.86), respectively. The model
effectively stratified patients by overall and disease-free survival
(all P < .05). RNA sequencing revealed
extracellular matrix remodeling, transforming growth
factor–β signaling, and M2 macrophage infiltration in high
optimal margin region–score tumors.

The optimal margin region–based radiomics model, derived from EOB
MRI, effectively captured tumor margin heterogeneity.

Keywords: MRI, Machine Learning, Radiomics, Radiogenomics,
Abdomen/GI, Liver, Surgery, High-Risk Solitary Hepatocellular Carcinoma,
Tumor Margin, Microvascular Invasion, Gd-EOB-DTPA-enhanced MRI,
OATP1B3

© The Author(s) 2026. Published by the Radiological Society of
North America under a CC BY 4.0 license.

Supplemental
material is available for this article.

## Linked entities

- **Chemicals:** Gadoxetic Acid (PubChem CID 25203894), Gd-EOB-DTPA (PubChem CID 53240376)
- **Diseases:** Hepatocellular Carcinoma (MONDO:0007256)

## Full-text entities

- **Genes:** MYCN (MYCN proto-oncogene, bHLH transcription factor) [NCBI Gene 4613] {aka FGLDS1, MODED, MPAPA, MYCNsORF, MYCNsPEP, N-myc}, MMRN1 (multimerin 1) [NCBI Gene 22915] {aka ECM, EMILIN4, GPIa*, MMRN}, SLC29A4 (solute carrier family 29 member 4) [NCBI Gene 222962] {aka ENT4, PMAT}, SIX2 (SIX homeobox 2) [NCBI Gene 10736], PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 5295] {aka AGM7, GRB1, IMD36, p85, p85-ALPHA, p85alpha}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, SLCO1A2 (solute carrier organic anion transporter family member 1A2) [NCBI Gene 6579] {aka OATP, OATP-A, OATP1A2, SLC21A3}, SLCO1B3 (solute carrier organic anion transporter family member 1B3) [NCBI Gene 28234] {aka HBLRR, LST-2, LST-3TM13, LST3, OATP-8, OATP1B3}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, MAFA (MAF bZIP transcription factor A) [NCBI Gene 389692] {aka INSDM, RIPE3b1, hMafA}, GGTLC4P (gamma-glutamyltransferase light chain 4 pseudogene) [NCBI Gene 729838] {aka GGT}, AFP (alpha fetoprotein) [NCBI Gene 174] {aka AFPD, FETA, HPAFP}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, ENTPD3 (ectonucleoside triphosphate diphosphohydrolase 3) [NCBI Gene 956] {aka CD39L3, HB6, NTPDase-3}, GGT1 (gamma-glutamyltransferase 1) [NCBI Gene 2678] {aka CD224, D22S672, D22S732, GGT, GGT 1, GGTD}
- **Diseases:** HR (MESH:D002303), cancer (MESH:D009369), OMR (MESH:D010437), HCC (MESH:D006528), metastasis (MESH:D009362), death (MESH:D003643), lesion (MESH:D009059), MVI (MESH:D017566)
- **Chemicals:** linsitinib (MESH:C551528), 17-AAG (MESH:C112765), EOB (-), Gadoxetic Acid (MESH:C073590), cAMP (MESH:D000242), PicroSirius red (MESH:C009798), paraffin (MESH:D010232), gadolinium (MESH:D005682)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12862467/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12862467/full.md

## References

52 references — full list in the complete paper: https://tomesphere.com/paper/PMC12862467/full.md

---
Source: https://tomesphere.com/paper/PMC12862467